Tratamiento de hepatitis crónica por virus de Hepatitis C con drogas antivirales de acción directa en un paciente con fibrosis quística

The development of new direct acting antiviral drugs for the treatment Hepatitis C virus infection, has made it possible to obtain an excellent cure rate and extend indications eradication previously very difficult populations treat like cystic fibrosis, in whom with classic regimens based on pegylated Interferon plus ribavirin could favor worsening lung function. We present a case 41-year-old man diagnosed genotype 1a, non-cirrhotic, treated twelve weeks, obtaining sustained viral response, without adverse effects. One year later, being waiting list, underwent bipulmonary transplant.